|
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
|
3R01CA183605-03S1
|
$374,707
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-03
|
$536,875
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-03
|
$164,937
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-04
|
$267,778
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-05
|
$317,475
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
1R01CA193350-01
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-02
|
$710,976
|
DIAMOND, DON
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-10
|
$2,185,000
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S1
|
$113,085
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S2
|
$53,400
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S3
|
$50,000
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S4
|
$124,999
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-32
|
$2,184,600
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-02
|
$496,292
|
ZAIA, JOHN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Lymphocyte trafficking blockade in allogeneic stem-cell transplantation
|
7K23CA178202-03
|
$170,856
|
RESHEF, RAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
2P01CA142106-11A1
|
$1,685,462
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-05
|
$1,988,528
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-03
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
|
5R01CA183559-03
|
$700,000
|
SOIFFER, ROBERT
|
DANA-FARBER CANCER INST
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-02
|
$127,865
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA014236-41
|
$5,661,203
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-41S1
|
$56,234
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-07
|
$357,376
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-02
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
5P01CA018029-40
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-37
|
$259,426
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-05
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-03
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-05
|
$151,059
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
2P30CA015704-40
|
$9,785,343
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S1
|
$28,376
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S2
|
$84,156
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S3
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-40S4
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation
|
1K01CA188151-01A1
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-13
|
$334,967
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-27
|
$2,206,479
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
|
5R01CA175008-03
|
$365,200
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-07
|
$560,424
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-17
|
$2,019,079
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
|
5R00CA154608-05
|
$249,000
|
TURTLE, CAMERON
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response
|
1R03CA197539-01
|
$84,250
|
PIDALA, JOSEPH
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|